US Market News
2 months ago
The Cigna Group Reports Strong First Quarter 2026 Results, Raises 2026 OutlookApril 30, 2026 6:00 AM
PR Newswire (US)
Total revenues for the first quarter 2026 increased 5% to $68.5 billionShareholders' net income for the first quarter 2026 was $1.7 billion, or $6.26 per shareAdjusted income from operations1 for the first quarter 2026 was $2.1 billion, or $7.79 per share2026 outlook2 for adjusted income from operations1,2 increased to at least $30.35 per share2BLOOMFIELD, Conn., April 30, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today reported first quarter 2026 results, reflecting growth across its diversified portfolio of businesses."We continue to improve how people experience health care, leveraging innovation and technology to make it more personalized, more transparent and easier to navigate," said David M. Cordani, chairman and CEO of The Cigna Group. "Our strong first quarter results were driven by disciplined execution, deliberate portfolio shaping and a continued focus on targeted innovation."Shareholders' net income for first quarter 2026 was $1.7 billion, or $6.26 per share compared to $1.3 billion, or $4.85 per share, for first quarter 2025, reflecting growth across the enterprise.The Cigna Group's adjusted income from operations1 for first quarter 2026 was $2.1 billion, or $7.79 per share, compared with $1.8 billion, or $6.74 per share, for first quarter 2025.A reconciliation of shareholders' net income to adjusted income from operations1 is provided on the following page and on Exhibit 1 of this earnings release.CONSOLIDATED HIGHLIGHTSThe following table includes highlights of results and reconciliations of total revenues to adjusted revenues3 and shareholders' net income to adjusted income from operations1:Consolidated Financial Results (unaudited, dollars in millions):
Three Months Ended
March 31,December 31,
202620252025
Total Revenues$ 68,494$ 65,502$ 72,472Net Investment Results from Equity Method
Investments323(50)23Adjusted Revenues3$ 68,517$ 65,452$ 72,495
Consolidated Earnings, net of taxes
Shareholders' Net Income$ 1,654$ 1,323$ 1,234Net Investment (Gains) Losses1(233)(48)104Amortization of Acquired Intangible Assets1315336327Special Items1322229483Adjusted Income from Operations1$ 2,058$ 1,840$ 2,148
Shareholders' Net Income, per share $ 6.26$ 4.85$ 4.64Adjusted Income from Operations1, per share $ 7.79$ 6.74$ 8.08Total revenues for first quarter 2026 increased 5% relative to first quarter 2025, primarily driven by growth in Evernorth Health Services, partially offset by the impact of the HCSC transaction4.Adjusted income from operations1 for first quarter 2026 increased 12% relative to first quarter 2025, driven by higher contributions primarily from Cigna Healthcare, as well as Evernorth Health Services.The SG&A expense ratio5 and adjusted SG&A expense ratio5 were 5.4% and 4.8% for first quarter 2026, compared to 6.4% and 5.8%, respectively, in first quarter 2025, reflecting business mix shift as well as improved operating efficiency.The debt-to-capitalization ratio was 42.3% at March 31, 2026, compared to 43.0% at December 31, 2025.CUSTOMER RELATIONSHIPSThe following table summarizes The Cigna Group's medical customers and overall customer relationships:Customer Relationships (in thousands):
As of the Periods Ended
March 31,December 31,
202620252025
Total Pharmacy Customers6121,020122,283123,603
U.S. Healthcare16,62316,36416,423International Health1,7111,6791,695Total Medical Customers618,33418,04318,118
Behavioral Care27,55823,41628,269Dental18,55818,46618,438
Total Customer Relationships6185,470182,208188,428Total customer relationships6 at March 31, 2026 decreased 2% from December 31, 2025 to 185.5 million.Total pharmacy customers6 at March 31, 2026 decreased 2% from December 31, 2025 to 121.0 million, reflecting expected client transitions and lower membership from health plan clients.Total medical customers6 at March 31, 2026 increased 1% from December 31, 2025 to 18.3 million reflecting growth in Middle, Select, and International markets, partially offset by lower membership in National Accounts.HIGHLIGHTS OF SEGMENT RESULTSSee Exhibit 1 for a reconciliation of adjusted income from operations1 to shareholders' net income. Evernorth Health ServicesThis segment includes the Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the health care system to work better and help people live healthier lives.Pharmacy Benefit Services drives high-quality, cost-effective pharmacy care through various services such as drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management and access to our home delivery pharmacy. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help our clients drive better whole-person health outcomes through care services.Financial Results (dollars in millions):
Three Months Ended
March 31,December 31,
202620252025Total Adjusted Revenues
Pharmacy Benefit Services$ 33,002$ 29,742$ 36,339 Specialty and Care Services$ 25,440$ 23,939$ 26,717Adjusted Revenues3$ 58,442$ 53,681$ 63,056Adjusted Income from Operations, Pre-Tax
Pharmacy Benefit Services$ 394$ 544$ 1,154Specialty and Care Services$ 1,072$ 890$ 1,034Adjusted Income from Operations, Pre-Tax1$ 1,466$ 1,434$ 2,188Margin, Pre-Tax72.5 %2.7 %3.5 %Evernorth Health Services first quarter 2026 adjusted revenues3 and adjusted income from operations, pre-tax1, increased 9% and 2%, respectively, relative to first quarter 2025.For Pharmacy Benefit Services first quarter 2026 relative to first quarter 2025:Adjusted revenues3 increased 11% primarily due to drug mix.Adjusted income from operations, pre-tax1, decreased 28%, primarily reflecting expected lower contributions from large client relationships, consistent with prior commentary.For Specialty and Care Services first quarter 2026 relative to first quarter 2025:Adjusted revenues3 increased 6% reflecting strong specialty volume growth.Adjusted income from operations, pre-tax1, increased 20% primarily reflecting strong organic growth in specialty businesses, including increased generic and biosimilar adoption that continues to lower costs for clients and patients.Cigna HealthcareThis segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. U.S. Healthcare provides medical plans and other benefits and solutions for insured and self-insured clients as well as individual and family plan customers. International Health provides health care solutions in our international markets, as well as health solutions for globally mobile individuals and employees of multinational organizations. U.S. Healthcare included the Medicare and related businesses until the divestiture of such businesses to Health Care Services Corporation ("HCSC")4 on March 19, 2025.Financial Results (dollars in millions):
Three Months Ended
March 31,December 31,
202620252025
Adjusted Revenues3,8$ 11,477$ 14,482$ 11,172Adjusted Income from Operations, Pre-Tax1$ 1,514$ 1,287$ 734Margin, Pre-Tax713.2 %8.9 %6.6 %First quarter 2026 adjusted revenues3,8 decreased 21% relative to first quarter 2025, primarily reflecting the impact of the HCSC transaction4,8. Excluding the impact of the HCSC transaction4,8, first quarter 2026 adjusted revenues3,8 increased 8% relative to first quarter 2025, primarily driven by premium rate increases to cover expected increases in medical costs.First quarter 2026 adjusted income from operations, pre-tax1, increased 18% relative to first quarter 2025, driven by improved margins in U.S. Healthcare across both U.S. Employer and Individual and Family Plan businesses.The Cigna Healthcare MCR5 was 79.8% for first quarter 2026, compared to 82.2% for first quarter 2025, primarily reflecting the impact of the HCSC transaction4.Cigna Healthcare net medical costs payable9 was $4.78 billion at March 31, 2026, $4.09 billion at December 31, 2025, and $4.37 billion at March 31, 2025. The sequential increase reflects typical stop loss seasonality. Favorable prior year reserve development on a gross pre-tax basis was $188 million and $222 million for the three months ended March 31, 2026 and 2025, respectively.Corporate and Other OperationsCorporate reflects interest expense, amounts not allocated to operating segments and includes intersegment eliminations. Other Operations is comprised of Corporate Owned Life Insurance ("COLI"), the Company's run-off operations and other non-strategic businesses.Financial Results (dollars in millions):
Three Months Ended
March 31,December 31,
202620252025
Adjusted (Loss) from Operations, Pre-Tax1$ (377)$ (411)$ (373)2026 OUTLOOK2The Cigna Group's outlook for full year 2026 consolidated adjusted income from operations1,2 is at least $30.35 per share2. Additionally, this outlook includes the impact of expected future share repurchases and anticipated 2026 dividends.(dollars in millions, except where noted and per share amounts)
2026 Consolidated MetricsProjection for Full Year EndingDecember 31, 2026Change from Prior ProjectionAdjusted Income from Operations, per share1,2at least $30.35+$0.10Evernorth Adjusted Income from Operations, Pre-Tax1,2at least $6,900
Cigna Healthcare Adjusted Income from Operations, Pre-Tax1,2at least $4,525+$25Cigna Healthcare Medical Care Ratio2,483.7% to 84.7%
The foregoing statements represent the Company's current estimates of The Cigna Group's 2026 consolidated and segment adjusted income from operations1,2 and other key metrics as of the date of this release. Actual results may differ materially depending on a number of factors. Investors are urged to read the Cautionary Note Regarding Forward-Looking Statements included in this release. Management does not assume any obligation to update these estimates.This quarterly earnings release and the Quarterly Financial Supplement are available on The Cigna Group's website in the Investor Relations section (https://investors.thecignagroup.com/overview/default.aspx). Management will be hosting a conference call to review first quarter 2026 results and discuss full year 2026 outlook beginning today at 8:30 a.m. ET. A link to the conference call is available in the Investor Relations section of The Cigna Group's website located at https://investors.thecignagroup.com/events-and-presentations/default.aspx. The call-in numbers for the conference call are as follows:Live Call
(888) 566-1889 (Domestic)
(773) 799-3989 (International)
Passcode: 04302026Replay
(866) 405-7290 (Domestic)
(203) 369-0603 (International)It is strongly suggested you dial in to the conference call by 8:15 a.m. ET.About The Cigna GroupThe Cigna Group (NYSE: CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Evernorth Health Services, Cigna Healthcare, or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 markets and jurisdictions, and has over 185 million customer relationships around the world. Learn more at thecignagroup.com.Notes:1. Adjusted income (loss) from operations is a principal financial measure of profitability used by The Cigna Group's management because it presents the underlying results of operations of the Company's businesses and facilitates analysis of trends in underlying revenue, expenses and shareholders' net income. Adjusted income (loss) from operations is defined as shareholders' net income (or income before income taxes less pre-tax income (loss) attributable to noncontrolling interests for the segment metric) excluding net investment gains/losses, amortization of acquired intangible assets and special items. The Cigna Group's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting are also excluded. Special items are matters that management believes are not representative of the underlying results of normal, recurring operations due to their nature or size. Adjusted income (loss) from operations is measured on an after-tax basis for consolidated results and on a pre-tax basis for segment results. Consolidated adjusted income (loss) from operations is not determined in accordance with GAAP and should not be viewed as a substitute for the most directly comparable GAAP measure, shareholders' net income. See Exhibit 1 for a reconciliation of consolidated adjusted income from operations to shareholders' net income.
2. Management is not able to provide a reconciliation of adjusted income from operations to shareholders' net income, on a forward-looking basis because it is unable to predict, without unreasonable effort, certain components thereof including (i) future net investment results and (ii) future special items. These items are inherently uncertain and depend on various factors, many of which are beyond The Cigna Group's control. As such, any associated estimate and its impact on shareholders' net income and total revenues could vary materially.
The Company's outlook excludes the potential effects of any other business combinations that may occur after the date of this earnings release. The Company's outlook includes the potential effects of expected future share repurchases and anticipated 2026 dividends.
The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. The share repurchase program may be effected through open market purchases in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended, including through Rule 10b5-1 trading plans, or privately negotiated transactions. The program may be suspended or discontinued at any time.
3. Adjusted revenues is used by The Cigna Group's management because it facilitates analysis of trends in underlying revenue. The Company defines adjusted revenues as total revenues excluding the following adjustments: special items and The Cigna Group's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting. Special items are matters that management believes are not representative of the underlying results of normal, recurring operations due to their nature or size. We exclude these items from this measure because management believes they are not indicative of past or future underlying performance of the business. Adjusted revenues is not determined in accordance with GAAP and should not be viewed as a substitute for the most directly comparable GAAP measure, total revenues. See Exhibit 1 for a reconciliation of consolidated adjusted revenues to total revenues.
4. On March 19, 2025, the company completed the sale (the "HCSC transaction") of its Medicare Advantage, Medicare Individual Stand-Alone Prescription Drug Plans, Medicare and Other Supplemental Benefits, and CareAllies businesses to Health Care Services Corporation ("HCSC").
5. Operating ratios are defined as follows:The Cigna Healthcare medical care ratio ("MCR") represents medical costs as a percentage of premiums for all Cigna Healthcare risk products provided through guaranteed cost or experience-rated funding arrangements. Changes in percentages may be expressed in basis points ("bps").SG&A expense ratio on a GAAP basis for the first quarter 2026 represents enterprise selling, general and administrative expenses of $3,722 million as a percentage of total revenue of $68.5 billion at a consolidated level. SG&A expense ratio on a GAAP basis for the first quarter 2025 represents enterprise selling, general and administrative expenses of $4,213 million as a percentage of total revenue of $65.5 billion at a consolidated level.Adjusted SG&A expense ratio for the first quarter 2026 represents enterprise selling, general and administrative expenses of $3,321 million excluding special items of $401 million as a percentage of adjusted revenue at a consolidated level. Adjusted SG&A expense ratio for the first quarter 2025 represents enterprise selling, general and administrative expenses of $3,799 million excluding special items of $414 million as a percentage of adjusted revenue at a consolidated level.6. Customer relationships are defined as follows:Total medical customers includes individuals who meet any one of the following criteria: (i) are covered under a medical insurance policy, managed care arrangement, or administrative services agreement issued by Cigna Healthcare; (ii) have access to Cigna Healthcare's provider network for covered services under their medical plan; or (iii) have medical claims that are administered by Cigna Healthcare.7. Margin, pre-tax, is calculated by dividing adjusted income (loss) from operations, pre-tax by adjusted revenues for each segment.8. The Cigna Group owns noncontrolling interests in certain operating joint ventures. As such, the adjusted revenues for the Cigna Healthcare segment only include the Company's share of the joint ventures' earnings reported in Fees and Other Revenues using the equity method of accounting under GAAP. Set forth below is a table that presents the impact of the HCSC transaction on Cigna Healthcare Adjusted Revenues for the periods presented. Management believes that the presentation of this measure is useful to investors because it permits a comparison of the Company's go-forward business across periods.Financial Results (dollars in millions):
Three Months Ended
March 31,December 31,
202620252025
Cigna Healthcare Adjusted Revenues3$ 11,477$ 14,482$ 11,172Less: U.S. Healthcare - divested businesses
revenues—3,850—Cigna Healthcare Adjusted Revenues3
excluding U.S. Healthcare - divested
businesses revenues$ 11,477$ 10,632$ 11,1729. Medical costs payable within the Cigna Healthcare segment are presented net of reinsurance and other recoverables. The gross medical costs payable balance was $4.92 billion as of March 31, 2026, $4.24 billion as of December 31, 2025, and $4.51 billion as of March 31, 2025.CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release, and oral statements made in connection with this release, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on The Cigna Group's current expectations and projections about future trends, events and uncertainties. These statements are not historical facts. Forward-looking statements may include, among others, statements concerning our projected outlook for 2026 (including adjusted revenues; adjusted income from operations, including on a per share, and segment basis; adjusted SG&A expense ratio; adjusted effective tax rate; cash flow from operations; capital expenditures; shareholder dividends; weighted average shares outstanding; medical care ratio; and total medical customers); future financial or operating performance, including our ability to improve the health and vitality of those we serve; future growth, business strategy and strategic or operational initiatives, including our ability to successfully implement actions across our business to strengthen our platform and build a more sustainable model for healthcare; economic, regulatory or competitive environments; capital deployment plans and amounts available for future deployment; our prospects for growth in the coming years; and other statements regarding The Cigna Group's future beliefs, expectations, plans, intentions, liquidity, cash flows, financial condition or performance. You may identify forward-looking statements by the use of words such as "believe," "expect," "project," "plan," "intend," "anticipate," "estimate," "predict," "potential," "may," "should," "will" or other words or expressions of similar meaning, although not all forward-looking statements contain such terms.Forward-looking statements are subject to risks and uncertainties, both known and unknown, that could cause actual results to differ materially from those expressed or implied in forward-looking statements. Such risks and uncertainties include, but are not limited to: our ability to manage health care costs and respond to price competition, inflation and other pressures that could compress our margins or result in premiums that are insufficient to cover the cost of services delivered to our customers; our ability to compete effectively, differentiate our products and services from those of our competitors and adapt to changes in an evolving and rapidly changing industry; our ability to develop and effectively implement products and services to improve the accessibility, affordability and transparency of health care; changes in drug pricing or industry pricing benchmarks; our ability to maintain relationships with one or more key pharmaceutical manufacturers or if payments made or discounts provided decline; changes in the pharmacy provider marketplace or pharmacy networks; the potential for actual claims to exceed our estimates related to expected medical claims; our ability to develop and maintain satisfactory relationships with health care payors, physicians, hospitals, other health service providers and with producers and consultants; potential liability in connection with managing medical practices and operating pharmacies, onsite clinics and other types of medical facilities; uncertainties surrounding participation in government-sponsored programs and providing services to payors who participate in government-sponsored programs; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; compliance with applicable privacy, security and data laws, regulations and standards; the outcome of litigation, regulatory audits and investigations; compliance costs and potential failure of our prevention, detection and control systems; our ability to invest in and properly maintain our information technology and other business systems; our ability to prevent or contain effects of a potential cyberattack or other privacy or data security incident; risks related to our use of artificial intelligence and machine learning; dependence on success of relationships with third parties; risk of significant disruption within our operations or among key suppliers or third parties; political, legal, operational, regulatory, economic and other risks that could affect our multinational operations, including currency exchange rates; risks related to strategic transactions and realization of the expected benefits of such transactions, as well as integration or separation difficulties or underperformance relative to expectations which could lead to an impairment charge; our ability to achieve our strategic and operational initiatives; unfavorable economic and market conditions, the risk of a recession or other economic downturn and resulting impact on employment metrics, stock market or changes in interest rates; risks related to a downgrade in financial strength ratings of our insurance subsidiaries; the impact of our significant indebtedness and the potential for further indebtedness in the future; credit risk related to our reinsurers; as well as more specific risks and uncertainties discussed in our most recent report on Form 10-K and subsequent reports on Forms 10-Q and 8-K available through the Investor Relations section of www.thecignagroup.com. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made, are not guarantees of future performance or results, and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. The Cigna Group undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by law.THE CIGNA GROUP
Exhibit 1COMPARATIVE SUMMARY OF FINANCIAL RESULTS (unaudited)
Three Months Ended
Three Months Ended
March 31,
December 31,(Dollars in millions, except per share amounts)
2026
2025
2025
REVENUES
Pharmacy revenues
$ 54,037
$ 48,633
$ 58,336Premiums
9,812
12,736
9,288Fees and other revenues
4,443
3,895
4,509Net investment income
202
238
339Total revenues
68,494
65,502
72,472Net investment results from certain equity method investments
23
(50)
23Adjusted revenues (1)
$ 68,517
$ 65,452
$ 72,495
Shareholders' net income
$ 1,654
$ 1,323
$ 1,234Pre-tax adjusted income (loss) from operations by segment
Evernorth Health Services
$ 1,466
$ 1,434
$ 2,188Cigna Healthcare
1,514
1,287
734Corporate and Other Operations
(377)
(411)
(373) Adjusted income tax expense
(545)
(470)
(401)Consolidated after-tax adjusted income from operations
$ 2,058
$ 1,840
$ 2,148
Weighted average shares (in thousands)
264,017
272,953
265,699Common shares outstanding (in thousands)
264,498
269,773
263,464SHAREHOLDERS' EQUITY at March 31,
$ 42,210
$ 40,226
SHAREHOLDERS' EQUITY PER SHARE at March 31,
$ 159.59
$ 149.11
Three Months Ended
Three Months Ended
March 31,
December 31,
2026
2025
2025(Dollars in millions, except per share amounts)Pre-taxAfter-tax
Pre-taxAfter-tax
Pre-taxAfter-tax
SHAREHOLDERS' NET INCOME
Shareholders' net income
$ 1,654
$ 1,323
$ 1,234Adjustments to reconcile adjusted income from operations
Net investment (gains) losses (2)$ (235)(233)
$ (48)(48)
$ 123104Amortization of acquired intangible assets390315
422336
463327Special Items
Strategic optimization program380290
215163
183136 Integration and transaction-related costs3527
216164
3021 Deferred tax expenses, net—16
—17
—374 (Gain) loss on sale of businesses—(3)
(41)(115)
66(48) (Benefits) associated with litigation matters(11)(8)
——
——Adjusted income from operations (3)
$ 2,058
$ 1,840
$ 2,148
DILUTED EARNINGS PER SHARE
Shareholders' net income
$ 6.26
$ 4.85
$ 4.64Adjustments to reconcile to adjusted income from operations
Net investment (gains) losses (2)$ (0.89)(0.88)
$ (0.18)(0.18)
$ 0.460.39Amortization of acquired intangible assets1.481.19
1.541.23
1.741.23Special Items
Strategic optimization program1.441.10
0.790.60
0.690.51 Integration and transaction-related costs0.130.10
0.790.60
0.110.08 Deferred tax expenses, net—0.06
—0.06
—1.41 (Gain) loss on sale of businesses—(0.01)
(0.15)(0.42)
0.25(0.18) (Benefits) associated with litigation matters(0.04)(0.03)
——
——Adjusted income from operations (3)
$ 7.79
$ 6.74
$ 8.08
(1) Adjusted revenues is defined as total revenues excluding the following adjustments: special items and The Cigna Group's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting. These items are excluded because they are not indicative of past or future underlying performance of our businesses.
(2) Includes Net investment gains/losses as presented in our Consolidated Statements of Income, as well as the Company's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting, which are presented within Fees and other revenues in our Consolidated Statements of Income.
(3) Adjusted income (loss) from operations is defined as shareholders' net income (or income before income taxes less pre-tax income (loss) attributable to noncontrolling interests for the segment metric) excluding the following adjustments: net investment gains/losses, amortization of acquired intangible assets and special items. The Cigna Group's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting are also excluded.INVESTOR RELATIONS CONTACT:
Ralph Giacobbe
860-787-7968
Ralph.Giacobbe @uniontown-6523
Justine.Sessions@Evernorth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-cigna-group-reports-strong-first-quarter-2026-results-raises-2026-outlook-302758031.htmlSOURCE The Cigna Group
Original: The Cigna Group Reports Strong First Quarter 2026 Results, Raises 2026 Outlook
US Market News
4 months ago
AM Best Affirms Credit Ratings of The Cigna Group and Its SubsidiariesMarch 4, 2026 5:40 PM
Business Wire
AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a+” (Excellent) of the key U.S. life/health subsidiaries and Europe-based insurance companies of The Cigna Group (Cigna) (headquartered in Bloomfield, CT) [NYSE: CI]. The majority of Cigna’s core U.S. health insurance entities are collectively referred to as Cigna Life & Health Group.
In addition, AM Best has affirmed the Long-Term ICR of “bbb+” (Good) and the Long-Term Issue Credit Ratings (Long-Term IR) of Cigna. AM Best also has affirmed the Short-Term Issue Credit Rating (Short-Term IR) of Cigna. The outlook of these Credit Ratings (ratings) is stable. (Please see below for a detailed listing of the companies and ratings.)
The ratings reflect Cigna Life & Health Group’s balance sheet strength, which AM Best assesses as strong, as well as its strong operating performance, favorable business profile and appropriate enterprise risk management (ERM).
Cigna Life & Health Group’s ratings continue to recognize its strongest level of risk-adjusted capitalization, as measured by Best’s Capital Adequacy Ratio (BCAR). The group’s balance sheet remains a core strength, characterized by strong liquidity and financial flexibility. Cigna Life & Health Group’s invested assets are held predominantly in investment grade fixed income securities and cash/cash equivalents, while maintaining moderate exposure to commercial mortgage-backed securities, private issues and below investment grade securities.
AM Best notes that Cigna Life & Health Group’s balance sheet strength assessment continues to be impacted by Cigna’s elevated financial leverage of just over 43%, as measured by AM Best, as well as its very high level of goodwill and intangible assets. Cigna’s debt service is supported by its strong earnings and dividends from the group’s insurance entities, as well as solid non-regulated earnings from its Evernorth Health Services segment. Cigna’s earnings before interest and taxes interest coverage remains good at over six times for 2025. Nevertheless, goodwill and intangibles assets remain high at approximately 176% of shareholder equity. The high goodwill/intangibles are predominantly related to non-insurance operations, Evernorth Health Services, contributes material non- regulated cash flow, stable earnings and substantial business diversification for Cigna. Cigna has reported strong operating cash flows through 2025. Cigna has excellent financial flexibility supported by parent company cash, insurance subsidiary dividend capacity, non-regulated cash flow, a commercial paper program and a $6.5 billion revolving credit agreement.
Cigna Life & Health Group has reported a solid level of revenue and operating earnings in its business segments over the last several years, driven by a high membership base and premium rate increases. The group’s revenues are geographically diversified across the United States, which supports the organization's operational strength. The sale of Cigna Group’s Medicare and CareAllies businesses in 2025 is expected to drive a decrease in overall revenues. Cigna Life & Health Group has consistently reported high levels of earnings and solid levels of return-on-equity measures among its peers. AM Best also notes that Cigna Life & Health Group continues to operate under a lower risk model as a majority of its business is commercial group health business with a high portion operated under self-funded/administrative services only employer group contracts. Earnings from the insurance operations have been driven largely by the group’s core commercial segment. AM Best expects Cigna Life & Health Group’s operating performance to remain favorable with possible improvement from the sale of its Medicare business, which had been a drag on earnings.
The organization continues to maintain a strong market presence in its core commercial employer health products in the United States. Through its affiliated noninsurance service entities, Cigna provides pharmacy benefit management services, as well as a comprehensive suite of solutions for complex and chronic conditions to drive down the cost of care. Furthermore, Cigna has expanded its customer base through cross-selling opportunities via the Evernorth Health Services arm, with further opportunity for premium, revenue and earnings growth for the overall organization.
The organization has a comprehensive ERM program with mature governance. The program is integrated into day-to-day operations and strategic business planning. Each business unit has its own heat map, which rolls up to an enterprise-level heat map. The organization also employs a formal risk appetite statement that includes key principles and key tolerances and limits. Cigna utilizes economic capital modeling and stress testing.
The ratings reflect CIGNA Life Insurance Company of Europe S.A.-N.V.’s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, neutral business profile, appropriate ERM and support from Cigna.
The ratings reflect CIGNA Global Insurance Company Limited’s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, neutral business profile, appropriate ERM and support from Cigna.
The FSR of A (Excellent) and the Long-Term ICRs of “a+” (Excellent) have been affirmed with stable outlooks for the following key U.S. life/health subsidiaries of The Cigna Life & Health Group:
Connecticut General Life Insurance Company
Cigna Health and Life Insurance Company
Cigna Worldwide Insurance Company
Cigna Dental Health Plan of Arizona, Inc.
Cigna Dental Health of California, Inc.
Cigna Dental Health of Florida, Inc.
Cigna Dental Health of Maryland, Inc.
Cigna Dental Health of Ohio, Inc.
Cigna Dental Health of Pennsylvania, Inc.
Cigna Dental Health of Texas, Inc.
Cigna Dental Health of New Jersey, Inc.
Cigna Dental Health of Missouri, Inc.
Cigna Dental Health of Virginia, Inc.
Cigna HealthCare of Indiana, Inc.
Cigna HealthCare of North Carolina, Inc.
Cigna HealthCare of South Carolina, Inc.
Cigna HealthCare of Georgia, Inc.
Cigna HealthCare of Texas, Inc.
Cigna HealthCare of Florida, Inc.
Cigna HealthCare of New Jersey, Inc.
Cigna HealthCare of Connecticut, Inc.
Cigna HealthCare of Illinois, Inc.
Cigna HealthCare of St. Louis, Inc.
Cigna HealthCare of Tennessee, Inc.
Cigna HealthCare of California, Inc
The FSR of A (Excellent) and the Long-Term ICRs of “a+” (Excellent) have been affirmed with stable outlooks for the following Europe-based subsidiaries of The Cigna Group:
CIGNA Life Insurance Company of Europe S.A. – N.V.
CIGNA Europe Insurance Company S.A. – N.V.
CIGNA Global Insurance Company Limited
The following Long-Term IRs have been affirmed with stable outlooks for The Cigna Group:
The Cigna Group—
- “bbb+” (Good) on $800 million ($550 million outstanding) of 1.25% senior unsecured notes, due 2026
- “bbb+” (Good) on $1 billion of 5% senior unsecured notes, due 2029
- “bbb+” (Good) on $1.5 billion ($1.4 billion outstanding) of 2.4% senior unsecured notes, due 2030
- “bbb+” (Good) on $1 billion of 4.5% senior unsecured notes, due 2030
- “bbb+” (Good) on $1.5 billion of 2.375% senior unsecured notes, due 2031
- “bbb+” (Good) on $750 million of 5.125% senior unsecured notes, due 2031
- “bbb+” (Good) on $1.25 billion of 4.875% senior unsecured notes, due 2032
- “bbb+” (Good) on $800 million of 5.4% senior unsecured notes, due 2033
- “bbb+” (Good) on $1.25 billion of 5.25% senior unsecured notes, due 2034
- “bbb+” (Good) on $1.5 billion of 5.25% senior unsecured notes, due 2036
- “bbb+” (Good) on $750 million of 3.2% senior unsecured notes, due 2040
- “bbb+” (Good) on $1.25 billion ($1.18 billion outstanding) of 3.4% senior unsecured notes, due 2050
- “bbb+” (Good) on $1.5 billion ($1.43 billion outstanding) of 3.4% senior unsecured notes, due 2051
- “bbb+” (Good) on $1.5 billion of 5.6% senior unsecured notes, due 2054
- “bbb+” (Good) on $750 million of 6% senior unsecured notes, due 2056
The following Short-Term IR has been affirmed:
The Cigna Group—
- AMB-2 (Satisfactory) on commercial paper program
The following indicative Long-Term IRs have been affirmed with stable outlooks:
The Cigna Group—
- “bbb+” (Good) on senior unsecured debt
- “bbb-” (Good) on preferred stock
The following Long-Term IRs have been affirmed with stable outlooks:
Cigna Holding Company—
- “bbb+” (Good) on $300 million ($81 million outstanding) of 7.875% of senior unsecured debentures, due 2027
- “bbb+” (Good) on $600 million ($50 million outstanding) of 3.05% senior unsecured notes, due 2027
- “bbb+” (Good) on $83 million ($13 million outstanding) of 8.08% senior unsecured step-down notes, due 2033
- “bbb+” (Good) on $500 million ($15 million outstanding) of 6.15% senior unsecured notes, due 2036
- “bbb+” (Good) on $300 million ($29 million outstanding) of 5.875% senior unsecured notes, due 2041
- “bbb+” (Good) on $750 million ($21 million outstanding) of 5.375% senior unsecured notes, due 2042
- “bbb+” (Good) on $1 billion ($32 million outstanding) of 3.875% senior unsecured notes, due 2047
This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.
AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.
Copyright © 2026 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260304847549/en/
Jennifer Asamoah
Senior Financial Analyst
+1 908 882 1637
jennifer.asamoah@ambest.com
Bridget Maehr
Director
+1 908 882 2080
bridget.maehr@ambest.com
James Kenfack
Financial Analyst
+3 120 808 2272
james.kenfack@ambest.com
Christopher Sharkey
Associate Director, Public Relations
+1 908 882 2310
christopher.sharkey@ambest.com
Al Slavin
Senior Public Relations Specialist
+1 908 882 2318
al.slavin@ambest.com
Original: AM Best Affirms Credit Ratings of The Cigna Group and Its Subsidiaries
US Market News
4 months ago
The Cigna Group Announces President & COO Brian Evanko to Succeed David M. Cordani as Chief Executive OfficerMarch 3, 2026 7:30 AM
PR Newswire (US)
Cordani to retire as chief executive officer on July 1, 2026, and will serve as executive chair of The Cigna Group Board of DirectorsEvanko elected to the company's Board of DirectorsCompany reaffirms 2026 Financial OutlookBLOOMFIELD, Conn., March 3, 2026 /PRNewswire/ -- The Cigna Group (NYSE: CI) today announced that David M. Cordani will retire as chief executive officer effective July 1, 2026, and become executive chair of The Cigna Group's Board of Directors. Brian Evanko, current president and chief operating officer, will succeed Cordani as CEO.
Throughout his tenure—including roles as president and chief executive officer of Cigna Healthcare and chief financial officer of The Cigna Group—Evanko has demonstrated visionary leadership and delivered consistently strong performance, while guiding the organization through periods of significant change. He currently oversees the company's business portfolio across Cigna Healthcare and Evernorth Health Services, driving transformative innovation and accelerating the use of data, technology, and AI to make health care simpler, more personalized, and more affordable."Brian is an exceptional leader and the right person to guide The Cigna Group into its next chapter," said Cordani. "The status quo in health care today is unsustainable. By leading from the front and making meaningful changes, we have delivered sustained impact for customers and strengthened the company strategically, operationally, and financially. Now is the right time to transition leadership to build on our progress and carry our momentum forward.""David and Brian have worked together for many years, and under their leadership, The Cigna Group is defining a new era in health care, centered on delivering more personalized and affordable care," said Eric Wiseman, lead independent director of the Board of Directors. "Brian's purpose-driven, performance-focused leadership, experience across every dimension of our business, and future-focused approach uniquely position him to be the company's next CEO.""As I assume this role, I am grateful to David for his mentorship and to our Board of Directors for their trust," Evanko said. "Over my nearly 30 years with the company, I have seen firsthand the strength of our businesses, the talent of our team, and our deep commitment to serving customers and clients. I am excited to build on our strong foundation as we work to further modernize health care, expand our reach, and fuel growth." Wiseman continued, "On behalf of the Board, I want to express our gratitude for David's vision and leadership over nearly 17 years as CEO. During his tenure, David championed programs that improved affordability for customers and clients with differentiated services and capabilities. He strategically expanded and shaped the portfolio – from a traditional insurer, serving 46 million customers and generating $18 billion of annual revenue to a global health company, serving 180 million customer relationships and growing annual revenue to $275 billion. As a result of this transformation, the company's total shareholder return increased by more than 750%. We are pleased that The Cigna Group will continue to benefit from David's insights and experience as Executive Chair."Cordani and Evanko will work closely during the transition period through July 1, 2026, when Evanko will assume the role of CEO and Cordani will become Executive Chair of the Board.Cordani concluded, "Leading The Cigna Group has been the privilege of a lifetime. I am especially proud of how our team has worked to build a stronger future—not just for today, but for the next generation. By focusing on the customer, delivering value, and driving positive change, we are making a difference, one person at a time."Reaffirmed Financial OutlookThe Company is reaffirming projected full year 2026 consolidated adjusted income from operations of at least $30.25 per share. The Company is also reaffirming 2026 Evernorth pre-tax adjusted income from operations of at least $6.9 billion, and Cigna Healthcare pre-tax adjusted income from operations of at least $4.5 billion.DisclosuresAdjusted income (loss) from operations is a principal financial measure of profitability used by The Cigna Group's management because it presents the underlying results of operations of The Cigna Group's businesses and facilitates analysis of trends in underlying revenue, expenses and shareholders' net income (loss). Adjusted income (loss) from operations is defined as shareholders' net income (loss) (or income (loss) before income taxes less pre-tax income (loss) attributable to noncontrolling interests for the segment metric) excluding net investment gains/losses, amortization of acquired intangible assets and special items. The Cigna Group's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting are also excluded. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. Adjusted income (loss) from operations is measured on an after-tax basis for consolidated results and on a pre-tax basis for segment results. Consolidated adjusted income (loss) from operations is not determined in accordance with GAAP and should not be viewed as a substitute for the most directly comparable GAAP measure, shareholders' net income (loss).Management is not able to provide a reconciliation of adjusted income from operations to shareholders' net income (loss) (including on a per share basis) on a forward-looking basis because it is unable to predict, without unreasonable effort, certain components thereof including (i) future net investment results and (ii) future special items. These items are inherently uncertain and depend on various factors, many of which are beyond The Cigna Group's control. As such, any associated estimate and its impact on shareholders' net income and total revenues could vary materially.CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release and oral statements made with respect to information contained in this press release, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on The Cigna Group's current expectations and projections about future trends, events and uncertainties. These statements are not historical facts. Forward-looking statements may include, among others, statements concerning our projected adjusted income from operations outlook for 2026 on a per share basis, and other statements regarding our future beliefs, expectations, plans, intentions, liquidity, cash flows, financial condition or performance. You may identify forward-looking statements by the use of words such as "believe," "expect," "project," "plan," "intend," "anticipate," "estimate," "predict," "potential," "may," "should," "will" or other words or expressions of similar meaning, although not all forward-looking statements contain such terms.Forward-looking statements are subject to risks and uncertainties, both known and unknown, that could cause actual results to differ materially from those expressed or implied in forward-looking statements. Such risks and uncertainties include, but are not limited to: our ability to manage healthcare costs and respond to price competition, inflation and other pressures that could compress our margins or result in premiums that are insufficient to cover the cost of services delivered to our customers; our ability to compete effectively, differentiate our products and services from those of our competitors and adapt to changes in an evolving and rapidly changing industry; our ability to develop and effectively implement products and services to improve the accessibility, affordability and transparency of health care; changes in drug pricing or industry pricing benchmarks; our ability to maintain relationships with one or more key pharmaceutical manufacturers or if payments made or discounts provided decline; changes in the pharmacy provider marketplace or pharmacy networks; the potential for actual claims to exceed our estimates related to expected medical claims; our ability to develop and maintain satisfactory relationships with health care payors, physicians, hospitals, other health service providers and with producers and consultants; potential liability in connection with managing medical practices and operating pharmacies, onsite clinics and other types of medical facilities; uncertainties surrounding participation in government-sponsored programs and providing services to payors who participate in government-sponsored programs; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; compliance with applicable privacy, security and data laws, regulations and standards; the outcome of litigation, regulatory audits and investigations; compliance costs and potential failure of our prevention, detection and control systems; our ability to invest in and properly maintain our information technology and other business systems; our ability to prevent or contain effects of a potential cyberattack or other privacy or data security incident; risks related to our use of artificial intelligence and machine learning; dependence on success of relationships with third parties; risk of significant disruption within our operations or among key suppliers or third parties; political, legal, operational, regulatory, economic and other risks that could affect our multinational operations, including currency exchange rates; risks related to strategic transactions and realization of the expected benefits of such transactions, as well as integration or separation difficulties or underperformance relative to expectations which could lead to an impairment charge; our ability to achieve our strategic and operational initiatives; unfavorable economic and market conditions, the risk of a recession or other economic downturn and resulting impact on employment metrics, stock market or changes in interest rates; risks related to a downgrade in financial strength ratings of our insurance subsidiaries; the impact of our significant indebtedness and the potential for further indebtedness in the future; credit risk related to our reinsurers; as well as more specific risks and uncertainties discussed in our most recent report on Form 10-K and subsequent reports on Forms 10-Q and 8-K available through the Investor Relations section of www.thecignagroup.com. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made, are not guarantees of future performance or results, and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. The Cigna Group undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by law.INVESTOR RELATIONS CONTACT:
Ralph Giacobbe
860-787-7968
Ralph.Giacobbe @uniontown-6523
Justine.Sessions@Evernorth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-cigna-group-announces-president--coo-brian-evanko-to-succeed-david-m-cordani-as-chief-executive-officer-302702404.htmlSOURCE The Cigna Group
Original: The Cigna Group Announces President & COO Brian Evanko to Succeed David M. Cordani as Chief Executive Officer
US Market News
5 months ago
The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases DividendFebruary 5, 2026 6:00 AM
PR Newswire (US)
Total revenues for 2025 increased 11% to $274.9 billionShareholders' net income for 2025 was $6.0 billion, or $22.18 per shareAdjusted income from operations1 for 2025 was $8.0 billion, or $29.84 per share2026 adjusted income from operations1 is projected to be at least $7.950 billion, or at least $30.25 per share2Board of Directors declared an increase in the quarterly dividend to $1.56 per shareBLOOMFIELD, Conn., Feb. 5, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today reported 2025 results, underscoring operational discipline and the strength of its complimentary portfolio of global health businesses.
"In 2025, we expanded access and support, lowered costs, and improved transparency for our customers and patients," said David M. Cordani, chairman and CEO of The Cigna Group. "As we enter the new year, we are well-positioned to build on this momentum, fueled by our innovations that leverage our diversified businesses and track record of strong financial performance."Shareholders' net income for fourth quarter 2025 was $1.2 billion, or $4.64 per share. This compares with $1.4 billion, or $5.13 per share, for fourth quarter 2024.The Cigna Group's adjusted income from operations1 for fourth quarter 2025 was $2.1 billion, or $8.08 per share, compared with $1.8 billion, or $6.64 per share, for fourth quarter 2024.Shareholders' net income for 2025 was $6.0 billion, or $22.18 per share. This compares with $3.4 billion, or $12.12 per share for 2024, which included a one-time non-cash after-tax investment loss of $2.7 billion, or $9.53 per share.The Cigna Group's adjusted income from operations1 for 2025 was $8.0 billion, or $29.84 per share, compared with $7.7 billion, or $27.33 per share, for 2024.A reconciliation of shareholders' net income to adjusted income from operations1 is provided on the following page and on Exhibit 1 of this earnings release.CONSOLIDATED HIGHLIGHTSThe following table includes highlights of results and reconciliations of total revenues to adjusted revenues3 and shareholders' net income to adjusted income from operations1:Consolidated Financial Results (unaudited, dollars in millions):
Three Months EndedYear Ended
December 31,December 31,
2025202420252024
Total Revenues$ 72,472$ 65,649$ 274,900$ 247,121Net Investment Results from Equity Method
Investments32334(249)(204)Special Item related to Impairment of dividend
receivable3———182Adjusted Revenues3$ 72,495$ 65,683$ 274,651$ 247,099
Consolidated Earnings, net of taxes
Shareholders' Net Income$ 1,234$ 1,424$ 5,957$ 3,434Net Investment (Gains) Losses1104(18)(90)2,529Amortization of Acquired Intangible Assets13273751,3251,347Special Items148364822431Adjusted Income from Operations1$ 2,148$ 1,845$ 8,014$ 7,741
Shareholders' Net Income, per share $ 4.64$ 5.13$ 22.18$ 12.12Adjusted Income from Operations1, per share $ 8.08$ 6.64$ 29.84$ 27.33Total revenues for fourth quarter 2025 and full year 2025 increased 10% and 11%, respectively, relative to fourth quarter 2024 and full year 2024, primarily driven by Evernorth Health Services and includes growth of existing client relationships and strong specialty pharmacy growth.Adjusted income from operations1 for fourth quarter 2025 increased 16% relative to fourth quarter 2024, driven by higher contributions primarily from Cigna Healthcare, as well as Evernorth Health Services.Adjusted income from operations1 for 2025 increased 4% from 2024, reflecting strong growth in Evernorth Health Services, primarily within Specialty and Care Services.The SG&A expense ratio4 and adjusted SG&A expense ratio4 were 5.0% and 4.7% for fourth quarter 2025, compared to 5.9% and 5.7% in fourth quarter 2024, and 5.3% and 5.0% for full year 2025, compared to 6.0% and 5.9%, for full year 2024, reflecting business mix shift.The debt-to-capitalization ratio was 43.0% at December 31, 2025, compared to 44.9% at September 30, 2025 and 43.8% at December 31, 2024.In 2025, the Company repurchased 11.9 million shares of common stock for approximately $3.6 billion.On February 5, 2026, the Company's Board of Directors declared a cash quarterly dividend of $1.56 per share of Cigna common stock to be paid on March 19, 2026 to shareholders of record as of the close of trading on March 5, 2026. This reflects an increase from the 2025 cash quarterly dividend of $1.51 per share.CUSTOMER RELATIONSHIPSThe following table summarizes The Cigna Group's medical customers and overall customer relationships:Customer Relationships (in thousands):
As of the Periods Ended
December 31,
20252024
Total Pharmacy Customers5123,603118,304
U.S. Healthcare16,42317,502International Health1,6951,645Total Medical Customers518,11819,147
Behavioral Care28,26923,932Dental18,43818,258Medicare Part D—2,571
Total Customer Relationships5188,428182,212Total customer relationships5 at December 31, 2025 increased 3% from December 31, 2024 to 188.4 million, reflecting new sales and the continued expansion of relationships in Pharmacy Benefit Services and Behavioral Care, partially offset by the HCSC transaction6.Total pharmacy customers5 at December 31, 2025 increased 4% from December 31, 2024 to 123.6 million due to new sales and the continued expansion of relationships.Total medical customers5 at December 31, 2025 decreased 5% from December 31, 2024 to 18.1 million, primarily reflecting the impact of the HCSC transaction6. Excluding the impact of the HCSC transaction6, total medical customers5 as of December 31, 2025 were consistent with December 31, 2024.Total behavioral customers5 at December 31, 2025 increased 18% from December 31, 2024 to 28.3 million due to the onboarding of a new government contract.HIGHLIGHTS OF SEGMENT RESULTSSee Exhibit 1 for a reconciliation of adjusted income from operations1 to shareholders' net income. Evernorth Health ServicesThis segment includes the Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the health care system to work better and help people live healthier lives.Pharmacy Benefit Services drives high-quality, cost-effective pharmacy care through various services such as drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management and access to our home delivery pharmacy. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help our clients drive better whole-person health outcomes through care services.Financial Results (dollars in millions):
Three Months EndedYear Ended
December 31,December 31,
2025202420252024Total Adjusted Revenues
Pharmacy Benefit Services$ 36,339$ 30,273$ 132,126$ 111,822 Specialty and Care Services$ 26,717$ 23,471$ 102,827$ 90,333Adjusted Revenues3$ 63,056$ 53,744$ 234,953$ 202,155Adjusted Income from Operations, Pre-Tax
Pharmacy Benefit Services$ 1,154$ 1,198$ 3,506$ 3,577Specialty and Care Services$ 1,034$ 948$ 3,715$ 3,424Adjusted Income from Operations, Pre-Tax1$ 2,188$ 2,146$ 7,221$ 7,001Margin, Pre-Tax73.5 %4.0 %3.1 %3.5 %Evernorth Health Services fourth quarter 2025 adjusted revenues3 and adjusted income from operations, pre-tax1, increased 17% and 2%, respectively, relative to fourth quarter 2024. For full year 2025, adjusted revenues3 and adjusted income from operations, pre-tax1, increased 16% and 3%, respectively, relative to 2024.For Pharmacy Benefit Services:Fourth quarter 2025 and full year 2025 adjusted revenues3 increased 20% and 18%, respectively, relative to the fourth quarter 2024 and full year 2024, reflecting strong organic growth, including the growth of existing client relationships, and new business.Fourth quarter 2025 and full year 2025 adjusted income from operations, pre-tax1, decreased 4% and 2%, relative to fourth quarter 2024 and full year 2024, reflecting strategic investments and initiatives to support business growth and improve the patient experience.For Specialty and Care Services:Fourth quarter 2025 and full year 2025 adjusted revenues3 both increased 14%, relative to fourth quarter 2024 and full year 2024, reflecting strong specialty volume growth.Fourth quarter 2025 and full year 2025 adjusted income from operations, pre-tax1, increased 9% and 8%, respectively, relative to fourth quarter 2024 and full year 2024, reflecting strong organic growth in specialty businesses, including increased adoption of biosimilars.Cigna HealthcareThis segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. U.S. Healthcare provides medical plans and other benefits and solutions for insured and self-insured clients as well as individual and family plan customers. International Health provides health care solutions in our international markets, as well as health solutions for globally mobile individuals and employees of multinational organizations. U.S. Healthcare included the Medicare and related businesses until the divestiture of such businesses to Health Care Services Corporation ("HCSC")6 on March 19, 2025.Financial Results (dollars in millions):
Three Months EndedYear Ended
December 31,December 31,
2025202420252024
Adjusted Revenues3,8$ 11,172$ 13,331$ 47,163$ 52,914Adjusted Income from Operations, Pre-Tax1$ 734$ 511$ 4,153$ 4,229Margin, Pre-Tax76.6 %3.8 %8.8 %8.0 %Fourth quarter 2025 and full year 2025 adjusted revenues3,8 decreased 16% and 11%, respectively, relative to fourth quarter 2024 and full year 2024, primarily reflecting the impact of the HCSC transaction6,8. Excluding the impact of the HCSC transaction6,8, fourth quarter 2025 and full year 2025 adjusted revenues3,8 increased 8% and 7%, respectively, relative to fourth quarter 2024 and full year 2024, primarily driven by premium rate increases to cover expected increases in medical costs.Fourth quarter 2025 adjusted income from operations, pre-tax1, increased 44% relative to fourth quarter 2024, primarily driven by higher contributions from stop loss products relative to the prior year. Full year 2025 adjusted income from operations, pre-tax1, decreased 2% relative to full year 2024, primarily due to lower contributions from the Individual and Family Plans business.The Cigna Healthcare MCR4 was 88.0% for fourth quarter 2025, compared to 87.9% for fourth quarter 2024. The Cigna Healthcare MCR4 was 84.4% for full year 2025, compared to 83.2% for full year 2024, primarily due to higher medical costs, driven by the Individual and Family Plans business.Cigna Healthcare net medical costs payable9 was $4.09 billion at December 31, 2025, $4.53 billion at September 30, 2025, and $4.86 billion at December 31, 2024. The sequential decrease was consistent with prior years, reflecting stop loss seasonality. The year-over-year decrease was primarily driven by the HCSC transaction6 which included $978 million in net medical costs payable9 at December 31, 2024. Favorable prior year reserve development on a gross pre-tax basis was $342 million and $456 million for 2025 and 2024, respectively.Corporate and Other OperationsCorporate reflects interest expense, amounts not allocated to operating segments and includes intersegment eliminations. Other Operations is comprised of Corporate Owned Life Insurance ("COLI"), the Company's run-off operations and other non-strategic businesses.Financial Results (dollars in millions):
Three Months EndedYear Ended
December 31,December 31,
20252024202520243
Adjusted (Loss) from Operations, Pre-Tax1$ (373)$ (424)$ (1,504)$ (1,697)2026 OUTLOOK2The Cigna Group's outlook2 for full year 2026 adjusted revenues2,3 is approximately $280.0 billion. The Cigna Group's outlook for full year 2026 consolidated adjusted income from operations1,2 is at least $7.950 billion, or at least $30.25 per share2. Additionally, this outlook includes the impact of expected future share repurchases and anticipated 2026 dividends.(dollars in millions, except where noted and per share amounts) 2026 Consolidated MetricsProjection for Full Year EndingDecember 31, 2026Adjusted Revenues2,3~$280,000Adjusted Income from Operations1,2at least $7,950Adjusted Income from Operations, per share1,2at least $30.25Adjusted SG&A Expense Ratio2,4~5.0%Adjusted Effective Tax Rate2,10~19.0%Cash Flow from Operations2~$9,000Capital Expenditures2~$1,300Shareholder Dividends2~$1,600Weighted Average Shares Outstanding (millions)2261 to 265
2026 Evernorth Metrics
Evernorth Adjusted Income from Operations, Pre-Tax1,2at least $6,900
2026 Cigna Healthcare Metrics
Cigna Healthcare Adjusted Income from Operations, Pre-Tax1,2at least $4,500Cigna Healthcare Medical Care Ratio2,483.7% to 84.7%Total Medical Customers2,5~18.1MThe foregoing statements represent the Company's current estimates of The Cigna Group's 2026 consolidated and segment adjusted income from operations1,2 and other key metrics as of the date of this release. Actual results may differ materially depending on a number of factors. Investors are urged to read the Cautionary Note Regarding Forward-Looking Statements included in this release. Management does not assume any obligation to update these estimates.This quarterly earnings release and the Quarterly Financial Supplement are available on The Cigna Group's website in the Investor Relations section (https://investors.thecignagroup.com/overview/default.aspx). Management will be hosting a conference call to review full year 2025 results and discuss full year 2026 outlook beginning today at 8:30 a.m. ET. A link to the conference call is available in the Investor Relations section of The Cigna Group's website located at https://investors.thecignagroup.com/events-and-presentations/default.aspx. The call-in numbers for the conference call are as follows: Live Call
(888) 566-1889 (Domestic)
(773) 799-3989 (International)
Passcode: 02052026 Replay
(866) 405-7290 (Domestic)
(203) 369-0603 (International)It is strongly suggested you dial in to the conference call by 8:15 a.m. ET.About The Cigna GroupThe Cigna Group (NYSE: CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Evernorth Health Services, Cigna Healthcare, or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 markets and jurisdictions, and has more than 185 million customer relationships around the world. Learn more at thecignagroup.com.Notes:1. Adjusted income (loss) from operations is a principal financial measure of profitability used by The Cigna Group's management because it presents the underlying results of operations of the Company's businesses and facilitates analysis of trends in underlying revenue, expenses and shareholders' net income. Adjusted income (loss) from operations is defined as shareholders' net income (or income before income taxes less pre-tax income (loss) attributable to noncontrolling interests for the segment metric) excluding net investment gains/losses, amortization of acquired intangible assets and special items. The Cigna Group's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting are also excluded. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. Adjusted income (loss) from operations is measured on an after-tax basis for consolidated results and on a pre-tax basis for segment results. Consolidated adjusted income (loss) from operations is not determined in accordance with GAAP and should not be viewed as a substitute for the most directly comparable GAAP measure, shareholders' net income. See Exhibit 1 for a reconciliation of consolidated adjusted income from operations to shareholders' net income. 2. Management is not able to provide a reconciliation of adjusted income from operations to shareholders' net income, on a forward-looking basis because it is unable to predict, without unreasonable effort, certain components thereof including (i) future net investment results and (ii) future special items. These items are inherently uncertain and depend on various factors, many of which are beyond The Cigna Group's control. As such, any associated estimate and its impact on shareholders' net income and total revenues could vary materially. The Company's outlook excludes the potential effects of any other business combinations that may occur after the date of this earnings release. The Company's outlook includes the potential effects of expected future share repurchases and anticipated 2026 dividends.The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. The share repurchase program may be effected through open market purchases in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended, including through Rule 10b5-1 trading plans, or privately negotiated transactions. The program may be suspended or discontinued at any time.3. Adjusted revenues is used by The Cigna Group's management because it facilitates analysis of trends in underlying revenue. The Company defines adjusted revenues as total revenues excluding the following adjustments: special items and The Cigna Group's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. We exclude these items from this measure because management believes they are not indicative of past or future underlying performance of the business. Adjusted revenues is not determined in accordance with GAAP and should not be viewed as a substitute for the most directly comparable GAAP measure, total revenues. See Exhibit 1 for a reconciliation of consolidated adjusted revenues to total revenues. 4. Operating ratios are defined as follows:The Cigna Healthcare medical care ratio ("MCR") represents medical costs as a percentage of premiums for all Cigna Healthcare risk products provided through guaranteed cost or experience-rated funding arrangements. Changes in percentages may be expressed in basis points ("bps").SG&A expense ratio on a GAAP basis for the fourth quarter 2025 represents enterprise selling, general and administrative expenses of $3,609 million as a percentage of total revenue of $72.5 billion at a consolidated level. SG&A expense ratio on a GAAP basis for the fourth quarter 2024 represents enterprise selling, general and administrative expenses of $3,865 million as a percentage of total revenue of $65.6 billion at a consolidated level.SG&A expense ratio on a GAAP basis for the full year 2025 represents enterprise selling, general and administrative expenses of $14,617 million as a percentage of total revenue of $274.9 billion at a consolidated level. SG&A expense ratio on a GAAP basis for the full year 2024 represents enterprise selling, general and administrative expenses of $14,844 million as a percentage of total revenue of $247.1 billion at a consolidated level.Adjusted SG&A expense ratio for the fourth quarter 2025 represents enterprise selling, general and administrative expenses of $3,430 million excluding special items of $179 million as a percentage of adjusted revenue at a consolidated level. Adjusted SG&A expense ratio for the fourth quarter 2024 represents enterprise selling, general and administrative expenses of $3,767 million excluding special items of $98 million as a percentage of adjusted revenue at a consolidated level.Adjusted SG&A expense ratio for the full year 2025 represents enterprise selling, general and administrative expenses of $13,691 million excluding special items of $926 million as a percentage of adjusted revenue at a consolidated level. Adjusted SG&A expense ratio for the full year 2024 represents enterprise selling, general and administrative expenses of $14,569 million excluding special items of $275 million as a percentage of adjusted revenue at a consolidated level.5. Customer relationships are defined as follows:Total medical customers includes individuals who meet any one of the following criteria: (i) are covered under a medical insurance policy, managed care arrangement, or administrative services agreement issued by Cigna Healthcare; (ii) have access to Cigna Healthcare's provider network for covered services under their medical plan; or (iii) have medical claims that are administered by Cigna Healthcare.Total customer relationships and total medical customers as of December 31, 2024, excluding the impact of the HCSC transaction6, were 179,712 thousand and 18,055 thousand, respectively.6. On March 19, 2025, the company completed the sale (the "HCSC transaction") of its Medicare Advantage, Medicare Individual Stand-Alone Prescription Drug Plans, Medicare and Other Supplemental Benefits, and CareAllies businesses to Health Care Services Corporation ("HCSC").7. Margin, pre-tax, is calculated by dividing adjusted income (loss) from operations, pre-tax by adjusted revenues for each segment.8. The Cigna Group owns noncontrolling interests in certain operating joint ventures. As such, the adjusted revenues for the Cigna Healthcare segment only include the Company's share of the joint ventures' earnings reported in Fees and Other Revenues using the equity method of accounting under GAAP. Set forth below is a table that presents the impact of the HCSC transaction on Cigna Healthcare Adjusted Revenues for the periods presented. Management believes that the presentation of this measure is useful to investors because it permits a comparison of the Company's go-forward business across periods.Financial Results (dollars in millions):
Three Months EndedYear Ended
December 31,December 31,
2025202420252024
Cigna Healthcare Adjusted Revenues3$ 11,172$ 13,331$ 47,163$ 52,914Less: U.S. Healthcare - divested businesses
revenues—2,9733,85012,348Cigna Healthcare Adjusted Revenues3
excluding U.S. Healthcare - divested
businesses revenues$ 11,172$ 10,358$ 43,313$ 40,5669. Medical costs payable within the Cigna Healthcare segment are presented net of reinsurance and other recoverables. The gross medical costs payable balance was $4.24 billion as of December 31, 2025, $4.68 billion as of September 30, 2025, and $5.02 billion as of December 31, 2024.10. The measure "adjusted effective tax rate" is not determined in accordance with GAAP and should not be viewed as a substitute for the most directly comparable GAAP measure, "consolidated effective tax rate". We define adjusted effective tax rate as the consolidated income tax rate applicable to the Company's pre-tax income excluding pre-tax income (loss) attributable to noncontrolling interests, net investment results, amortization of acquired intangible assets, and special items. The Cigna Group's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting are also excluded. Management is not able to provide a reconciliation to the consolidated effective tax rate on a forward-looking basis because we are unable to predict, without unreasonable effort, certain components thereof including (i) future net investment results and (ii) future special items.CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release, and oral statements made in connection with this release, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on The Cigna Group's current expectations and projections about future trends, events and uncertainties. These statements are not historical facts. Forward-looking statements may include, among others, statements concerning our projected outlook for 2026 (including adjusted revenues; adjusted income from operations, including on a per share, and segment basis; adjusted SG&A expense ratio; adjusted effective tax rate; cash flow from operations; capital expenditures; shareholder dividends; weighted average shares outstanding; medical care ratio; and total medical customers); future financial or operating performance, including our ability to improve the health and vitality of those we serve; future growth, business strategy and strategic or operational initiatives, including our ability to successfully implement actions across our business to strengthen our platform and build a more sustainable model for healthcare; economic, regulatory or competitive environments; capital deployment plans and amounts available for future deployment; our prospects for growth in the coming years; and other statements regarding The Cigna Group's future beliefs, expectations, plans, intentions, liquidity, cash flows, financial condition or performance. You may identify forward-looking statements by the use of words such as "believe," "expect," "project," "plan," "intend," "anticipate," "estimate," "predict," "potential," "may," "should," "will" or other words or expressions of similar meaning, although not all forward-looking statements contain such terms.Forward-looking statements are subject to risks and uncertainties, both known and unknown, that could cause actual results to differ materially from those expressed or implied in forward-looking statements. Such risks and uncertainties include, but are not limited to: our ability to manage healthcare costs and respond to price competition, inflation and other pressures that could compress our margins or result in premiums that are insufficient to cover the cost of services delivered to our customers; our ability to compete effectively, differentiate our products and services from those of our competitors and adapt to changes in an evolving and rapidly changing industry; changes in drug pricing or industry pricing benchmarks; our ability to efficiently transition to a new rebate-free pricing model; our ability to maintain relationships with one or more key pharmaceutical manufacturers or if payments made or discounts provided decline; changes in the pharmacy provider marketplace or pharmacy networks; the potential for actual claims to exceed our estimates related to expected medical claims; our ability to develop and maintain satisfactory relationships with health care payors, physicians, hospitals, other health service providers and with producers and consultants; potential liability in connection with managing medical practices and operating pharmacies, onsite clinics and other types of medical facilities; uncertainties surrounding participation in government-sponsored programs and providing services to payors who participate in government-sponsored programs; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; compliance with applicable privacy, security and data laws, regulations and standards; the outcome of litigation, regulatory audits and investigations; compliance costs and potential failure of our prevention, detection and control systems; our ability to invest in and properly maintain our information technology and other business systems; our ability to prevent or contain effects of a potential cyberattack or other privacy or data security incident; risks related to our use of artificial intelligence and machine learning; dependence on success of relationships with third parties; risk of significant disruption within our operations or among key suppliers or third parties; political, legal, operational, regulatory, economic and other risks that could affect our multinational operations, including currency exchange rates; risks related to strategic transactions and realization of the expected benefits of such transactions, as well as integration or separation difficulties or underperformance relative to expectations which could lead to an impairment charge; our ability to achieve our strategic and operational initiatives; unfavorable economic and market conditions, the risk of a recession or other economic downturn and resulting impact on employment metrics, stock market or changes in interest rates; risks related to a downgrade in financial strength ratings of our insurance subsidiaries; the impact of our significant indebtedness and the potential for further indebtedness in the future; credit risk related to our reinsurers; as well as more specific risks and uncertainties discussed in our most recent report on Form 10-K and subsequent reports on Forms 10-Q and 8-K available through the Investor Relations section of www.thecignagroup.com. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made, are not guarantees of future performance or results, and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. The Cigna Group undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by law.THE CIGNA GROUP
Exhibit 1COMPARATIVE SUMMARY OF FINANCIAL RESULTS (unaudited)
Three Months Ended
Year Ended
December 31,
December 31,
(Dollars in millions, except per share amounts)
2025
2024
2025
2024
REVENUES
Pharmacy revenues
$ 58,336
$ 49,941
$ 216,672
$ 185,362
Premiums
9,288
11,503
40,261
45,996
Fees and other revenues
4,509
3,928
16,921
14,790
Net investment income
339
277
1,046
973
Total revenues
72,472
65,649
274,900
247,121
Net investment results from certain equity method investments
23
34
(249)
(204)
Special item related to impairment of dividend receivable
—
—
—
182
Adjusted revenues (1)
$ 72,495
$ 65,683
$ 274,651
$ 247,099
Shareholders' net income
$ 1,234
$ 1,424
$ 5,957
$ 3,434
Pre-tax adjusted income (loss) from operations by segment
Evernorth Health Services
$ 2,188
$ 2,146
$ 7,221
$ 7,001
Cigna Healthcare
734
511
4,153
4,229
Corporate and Other Operations
(373)
(424)
(1,504)
(1,697)
Adjusted income tax expense
(401)
(388)
(1,856)
(1,792)
Consolidated after-tax adjusted income from operations
$ 2,148
$ 1,845
$ 8,014
$ 7,741
Weighted average shares (in thousands)
265,699
277,784
268,563
283,218
Common shares outstanding (in thousands)
263,464
273,789
SHAREHOLDERS' EQUITY at December 31,
$ 41,713
$ 41,033
SHAREHOLDERS' EQUITY PER SHARE at December 31,
$ 158.33
$ 149.87
Three Months Ended
Year Ended
December 31,
December 31,
2025
2024
2025
2024
(Dollars in millions, except per share amounts)Pre-taxAfter-tax
Pre-taxAfter-tax
Pre-taxAfter-tax
Pre-taxAfter-tax
SHAREHOLDERS' NET INCOME
Shareholders' net income
$ 1,234
$ 1,424
$ 5,957
$ 3,434
Adjustments to reconcile adjusted income from operations
Net investment losses (gains) (2)$ 123104
$ (34)(18)
$ (225)(90)
$ 2,5332,529
Amortization of acquired intangible assets463327
424375
1,7431,325
1,7031,347
Special Items
Deferred tax expenses, net—374
—9
—427
—84
Strategic optimization program183136
——
749565
——
Integration and transaction-related costs3021
9876
327247
275211
Net loss (gain) on sale of businesses66(48)
(130)(21)
(13)(404)
(24)(2)
Benefits associated with litigation matters——
——
(17)(13)
——
Impairment of dividend receivable——
——
——
182138
Adjusted income from operations (3)
$ 2,148
$ 1,845
$ 8,014
$ 7,741
DILUTED EARNINGS PER SHARE
Shareholders' net income
$ 4.64
$ 5.13
$ 22.18
$ 12.12
Adjustments to reconcile to adjusted income from operations
Net investment losses (gains) (2)$ 0.460.39
$ (0.12)(0.06)
$ (0.84)(0.34)
$ 8.958.93
Amortization of acquired intangible assets1.741.23
1.531.34
6.504.94
6.014.76
Special Items
Deferred tax expenses, net—1.41
—0.03
—1.59
—0.30
Strategic optimization program0.690.51
——
2.782.10
——
Integration and transaction-related costs0.110.08
0.350.27
1.220.92
0.970.75
Net loss (gain) on sale of businesses0.25(0.18)
(0.47)(0.07)
(0.05)(1.50)
(0.08)(0.02)
Benefits associated with litigation matters——
——
(0.06)(0.05)
——
Impairment of dividend receivable——
——
——
0.640.49
Adjusted income from operations (3)
$ 8.08
$ 6.64
$ 29.84
$ 27.33
(1) Adjusted revenues is defined as total revenues excluding the following adjustments: special items and The Cigna Group's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting. These items are excluded because they are not indicative of past or future underlying performance of our businesses.(2) Includes Net investment gains/losses as presented in our Consolidated Statements of Income, as well as the Company's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting, which are presented within Fees and other revenues in our Consolidated Statements of Income.(3) Adjusted income (loss) from operations is defined as shareholders' net income (or income before income taxes less pre-tax income (loss) attributable to noncontrolling interests for the segment metric) excluding the following adjustments: net investment gains/losses, amortization of acquired intangible assets and special items. The Cigna Group's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting are also excluded.INVESTOR RELATIONS CONTACT:
Ralph Giacobbe
860-787-7968
Ralph.Giacobbe @uniontown-6523
Justine.Sessions@Evernorth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-cigna-group-reports-strong-fourth-quarter-and-full-year-2025-results-establishes-2026-outlook-and-increases-dividend-302679556.htmlSOURCE The Cigna Group
Original: The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend
US Market News
5 months ago
VINCENT COUNTRY SAFE ZONE ACTIVITY DAY PRESENTED BY CIGNA HEALTHCARE DELIVERS SUPER BOWL WEEK FUN, NFL FLAG FOOTBALL, AND WELLNESS TO OAKLAND STUDENTSFebruary 3, 2026 8:17 PM
PR Newswire (US)
Corporate, Nonprofit, and Philanthropic Partners Collaborated to Provide Transformative Experiences and Lasting Resources at Burckhalter Elementary SchoolOAKLAND, Calif., Feb. 3, 2026 /PRNewswire/ -- Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare, a flagship initiative of Love Thy Neighbor CDC co-founded by NFL Executive and Legend Troy Vincent, Sr. and his wife, author and chef Tommi A. Vincent, took place Tuesday, February 3, at Burckhalter Elementary School in Oakland, CA. The ninth annual event, themed Dreams Grow Here, delivered a full day of fun, food, wellness, and engaging sports activities, including NFL FLAG, for more than 200 Pre-K through fifth-grade students.
The day opened with a ceremonial ribbon-cutting celebrating a collective investment in the future of Burckhalter Elementary School and the unveiling of permanent campus enhancements, including a new soccer turf field, an adaptive agility mat, a fully stocked on-site food pantry, and a community mural. Joined by NFL Legends, current players, and corporate and philanthropic partners, the Vincent family continued to drive meaningful, school-centered impact in Super Bowl host communities. Since its inception, Safe Zone Activity Day has positively impacted more than 4,800 students and 640 educators, contributing nearly $745,000 in funding and critical wish-list resources to participating schools. "For nine years, Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare has been about more than a single moment, it has been about showing students and educators what is possible when a community truly invests in their dreams," said Tommi A. Vincent, co-founder of Love Thy Neighbor CDC. "By supporting the whole child – physically, emotionally, academically, and creatively – and celebrating the educators who guide them every day, we helped create an environment where children felt seen, supported, and inspired.""Our work has always been rooted in the belief that when children feel supported and inspired, their confidence grows, their potential expands, and their dreams begin to take shape," said Troy Vincent, Sr., NFL Executive and co-founder of Love Thy Neighbor CDC. "Bringing together NFL Legends, current players, and committed corporate and philanthropic partners during Super Bowl week allowed us to deliver meaningful, lasting impact for students and schools in this community."Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare brought together an extraordinary coalition of corporate, nonprofit, and philanthropic partners to deliver a full-spectrum experience supporting student wellness, education, and long-term opportunity. Cigna Healthcare activities included game stations for the kids; free health screenings and skin cancer checks in their Wellness In Motion mobile clinic for parents, faculty and the community; free eye exams and glasses for the children courtesy of Cigna Healthcare Vision; and mind-body wellness activations for students and staff led by the company's Evernorth Behavioral Health team."Since day one, we have proudly teamed up with Vincent Country on their Safe Zone Activity Day, united by our shared goal of improving the health and vitality of children, educators, and local communities," said Eric Sodergren, Senior Vice President of National Accounts at Cigna Healthcare. "From preventive health and vision screenings to mental wellness, we are offering access to care and early intervention essential to helping young people reach their full potential. We are honored to continue investing in communities alongside the Vincent family and partners who share our commitment."New partner, the Playing for Keeps Association made a transformational investment in Burckhalter Elementary School by supporting the installation of its first-ever full-size turf soccer field - creating the only dedicated green space on campus - and by providing an agility mat designed to support inclusive movement and physical development. Together, these improvements will give students a safe place to play, run, and be active, while ensuring that students in the special needs community have access to adaptive resources that support coordination, confidence, and joyful participation in physical activity."Every child deserves a safe place to move, play, and simply be a kid," said Dr. Mimi Nartey, President of the Playing for Keeps Association. "By bringing the first-ever full-size turf soccer field to Burckhalter Elementary School – and by providing a play-based agility mat designed to support inclusive movement – we are investing in an environmentally and economically sustainable play space that serves the full diversity of this campus. These play spaces will provide consistent, high-quality access to daily movement, confidence-building, and joy – while reducing long-term maintenance demands and maximizing the impact of limited school resources. We're proud to partner with Troy and Tommi Vincent and the Safe Zone Activity Day community to help create a space where energy, imagination and opportunity can thrive."Zebra Technologies, an early and long-standing Vincent Country Safe Zone Activity Day partner, continues to support student learning and creative expression through meaningful investments that leave a lasting presence at the school, including a permanent mural created by a local artist which was showcased at the start of the day."As one of Safe Zone Activity Day's longest partners, Zebra Technologies is thrilled to join Troy and Tommi Vincent in their commitment to support student learning and strengthen school communities," said Bill Burns, CEO of Zebra Technologies. "By providing books for student backpacks and partnering with a local muralist to create a permanent work of art unveiled at the start of the day, we aim to leave behind a meaningful expression of creativity, inspiration, and pride that will resonate with students and educators for years to come. Giving back and making a positive impact in local communities is core to Zebra's culture and values, and we are honored to be part of the incredible legacy of Safe Zone Activity Day."Stand Together, a philanthropic community that helps America's boldest changemakers tackle the root causes of our country's biggest issues, is in its second year of partnership with Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare. This year, Stand Together provided support through connections with groups in the community that help students and families overcome challenges, on-the-ground volunteering, and by producing content that shares the stories of how programs like these help people, to inspire others to get engaged."When kids are seen, supported, and encouraged, entire communities are strengthened," said Brian Hooks, Chairman and CEO of Stand Together. "We are grateful to partner with Troy and Tommi Vincent to show what's possible when you believe in people."Stand Together and Cigna Healthcare supported the participation of the Kevin Love Fund who provided mental health resources focused on equity, education, and reducing stigma around mental wellness for the teachers.With a focus on working together to end community hunger, Chick-fil-A, Inc., a second-year partner of Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare, teamed with local Owner-Operator Jon Hooper to provide boxed meals for students, faculty, staff, and volunteers, while also donating a fully stocked on-site food pantry accessible to the Burckhalter Elementary School community. Ongoing support for the pantry will be sustained through a partnership with the San Francisco 49ers and Safeway, extending the impact beyond the event day and helping address both immediate nourishment and long-term food security needs."At Chick-fil-A, caring for communities is rooted in our purpose, and we're honored to be a part of Safe Zone Activity Day by serving students, educators, and volunteers with Love Thy Neighbor CDC," said Brent Fielder, Vice President of Global Impact at Chick-fil-A, Inc. "In providing meals and supporting the donation of an on-site food pantry, we hope to meet both immediate needs and create a lasting resource for families to strengthen this school community."Infinite Athlete, a long-standing partner of Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare continued its support this year with a financial contribution designed to meet the evolving needs of the Burckhalter Elementary School community. Having previously donated playground and recreational equipment, Infinite Athlete's investment this year provides the school with flexible resources to allocate where they are needed most, reinforcing the program's commitment to meaningful, school-centered impact in Super Bowl host communities. "Our partnership with Vincent Country is rooted in shared values around equity, access, and long-term community investment," said Annie Gerhart-Ramsay, Co-founder and COO, Infinite Athlete. "By providing flexible support this year, we're helping ensure Burckhalter Elementary has the resources it needs to serve students in meaningful and lasting ways, today at Safe Zone Activity Day and beyond."Google joined as a new partner this year and engaged students throughout the day with hands-on STEM learning experiences designed to spark curiosity, creativity, and problem-solving skills, while also offering students a future field trip to its local headquarters to further explore technology and innovation. "At Google, we believe early exposure to STEM helps students build confidence, curiosity, and critical problem-solving skills," said Yolanda Washington, Lead Senior Program Manager, Talent Resilience & Community Engagement at Google. "We're excited to join Safe Zone Activity Day by engaging students in hands-on STEM experiences that introduce them to technology in creative and accessible ways. By extending this experience beyond the classroom through a future visit to our headquarters, we hope to inspire students to imagine new possibilities for their learning and their futures."First year partner Under Amour provided gear for volunteers and staff, as well as backpacks and gear for all Burckhalter Elementary School students. "We are honored to partner with Vincent Country Safe Zone Activity Day to continue to show our support for students in Oakland," said Flynn Burch, Under Armour Director of Global Community Impact & UA Next. "With our on-going engagement in Oakland Unified Schools and Oakland Athletic League – this opportunity reaffirms our commitment to these students to ensure they feel supported, garner confidence and reach their greatest potential on the field, in the classroom, and in the community."Students at Burckhalter Elementary School participated in team-building activities through a fun, competitive, and inclusive NFL FLAG experience played on the school's newly installed soccer turf field. Led by NFL Global Flag Football Ambassador Bobby Taylor — an NFL Legend and 10-year veteran of the Philadelphia Eagles and Seattle Seahawks — the activation reflected the league's continued investment in youth participation and access to the game. The new turf field serves as a permanent campus enhancement designed to support year-round student recreation and wellness. During Super Bowl week, NFL FLAG programming at Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare underscored flag football as a cornerstone of the sport's future, expanding access for thousands of schools, communities, and families nationwide."We are truly honored and grateful that Vincent Country selected Burckhalter Elementary School as this year's Safe Zone Activity Day school," said Carin Geathers, Principal of Burckhalter Elementary School. "The generosity of Troy and Tommi Vincent, along with the many partners who came together, has transformed our campus and provided our students and educators with critical resources that will have a lasting impact. From health and wellness support to learning materials and creative spaces that inspire pride and possibility, this day represents what is possible when a community rallies around its children and invests in their future."NFL Legend and Vincent Country Safe Zone Activity Day coach Eddie Mason once again facilitated the exercise challenges and was joined again by famed choreographer and producer Markus Shields who led the dance fitness fun, along with Troy Vincent, Sr., Takeo Spikes, and a host of volunteers including NFL staff, RISE, and a host of HBCU undergraduate and graduate students from around the country.Following Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare and school dismissal, educators, faculty, and staff at Burckhalter Elementary School gathered on campus for a dedicated Faculty and Staff Empowerment Session designed to support leadership, well-being, and professional growth. Sponsored by Chase, the session featured an empowerment speaker and leadership coach who engaged educators in reflection, inspiration, and practical tools to support both personal and professional resilience. Participants enjoyed a catered luncheon by San Francisco-based Old Skool Cafe, creating space for connection, appreciation, and restoration at the close of the day."Educators are the foundation of every school community, and supporting them is essential to student success," said Oscar Lopez, Chase's Senior Business Consultant in Oakland. "At Chase, we recognize that strong schools and dedicated educators are key to thriving communities and long-term growth. We're proud to sponsor the Faculty and Staff Empowerment Session to invest in the well-being and leadership of those who shape our future—and our economy."Later in the week, the Vincent's will host their signature luncheon Stay A While: Breaking Bread with the Vincents. Tommi Vincent, also known as Chef Tommi V., will collaborate with Oakland chef and entrepreneur – Chef Christina "Lala" Harrison. Together they will showcase their culinary talents while celebrating school leadership and thanking corporate sponsors.Continuing this year is the virtual fundraising component that accompanies Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare where additional funds and "wish list" items are raised to further benefit Burckhalter Elementary School. This year's virtual team captains are NFL Legends: Troy Vincent, and former (Oakland) Raiders: former Heisman Trophy winner and Pro Football Hall of Fame recipient, Tim Brown, College Football Hall of Fame inductee Lincoln Kennedy, and Lorenzo Alexander. The results of the online fundraiser will be announced later in the week. Please visit the Love Thy Neighbor CDC site to show your support and additional online auction information.ABOUT: Love Thy Neighbor Community Development & Opportunity Corporation (LTN) partners with schools, food suppliers, resource providers, and corporations to meet diverse community needs. Their efforts address educational inequities, provide school supplies, support youth leadership, create safe activities, and ensure year-round access to nutritious meals. Currently, LTN focuses on elementary education and domestic violence prevention. For more information visit: https://www.ltncdc.org/ABOUT VINCENT COUNTRY: Vincent Country is the family lifestyle brand committed to positive social impact. Developed by Troy and Tommi A. Vincent, the family is leading and enriching the culture and communities through intentional service and legacy-inspired cooking. Vincent Country is informed by a lifetime commitment to service, through this mantra the Vincent's established Love Thy Neighbor Community Development and Opportunity Corporation (LTN). Every year during the Super Bowl, Vincents host multiple community-focused events and partner with various organizations and companies, including school systems, food suppliers, and resource providers. Vincent Country pays homage to the accomplishments and the strength of the family unit and provides inspiration for families committed to building strong, secure, and sustainable relationships based on the principles of "Faith, Family, Food." For more information visit: www.vincentcountry.comABOUT CIGNA HEALTHCARE: Cigna Healthcare is a health benefits provider that advocates for better health through every stage of life. We guide our customers through the health care system, empowering them with the information and insight they need to make the best choices for improving their health and vitality. Products and services are provided exclusively by or through operating subsidiaries of The Cigna Group (NYSE: CI), including Cigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Evernorth Health companies or their affiliates and Express Scripts companies or their affiliates. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and others. Learn more at www.cignahealthcare.com.ABOUT PLAYING FOR KEEPS ASSOCIATION: The Playing for Keeps Association is a nonprofit organization dedicated to expanding equitable access to high-quality sports and play infrastructure in underserved communities. The organization supports the installation of sustainable athletic facilities and facilitates programming that advances youth development, public health, and community cohesion. For mor information visit: https://playing4keeps.org/ABOUT ZEBRA TECHNOLOGIES: Zebra provides the foundation for intelligent operations with an award-winning portfolio of connected frontline, asset visibility and automation solutions powered by AI. Organizations globally across retail, manufacturing, transportation, logistics, healthcare, and other industries rely on us to deliver outcomes today while driving innovation for what's next. Together with our partners, we create new ways of working that improve productivity and empower organizations to be better every day. Learn more at www.zebra.com. Follow Zebra on our Blog, LinkedIn, Facebook, X, Instagram and YouTube.ABOUT STAND TOGETHER:
Stand Together is a philanthropic community that tackles the root causes of our country's biggest problems. They partner with the country's boldest changemakers to drive solutions on education, economic opportunity, bridging divides, and dozens of other pressing issues. Learn more at www.standtogether.org and Facebook, X, LinkedIn, Instagram, and YouTube.ABOUT CHICK-FIL-A: About Chick-fil-A, Inc.
Chick-fil-A, Inc. is the third largest quick-service restaurant?company?in the United States, known for its freshly-prepared food, signature hospitality and unique franchise model. More than 200,000 Team Members are employed by local?Owner-Operators in more than 3,000 restaurants across the United States, Canada, Puerto Rico, the UK and Singapore.Chick-fil-A local Owner-Operators live and work in the communities their restaurants serve,?each supporting local efforts and making a positive impact. Chick-fil-A gives back through programs including Shared Table, True Inspiration Awards and Scholarships. The family-owned and privately held company got its start in 1946, founded by S. Truett Cathy.?More information on Chick-fil-A is available at?www.chick-fil-a.com and?Chick-fil-A Press Room. ABOUT INFINITE ATHLETE:
Born out of the idea that we can do better in all aspects of sports and live events – the fan, the game, and the athlete experience, Infinite Athlete's mission is to create a single technological foundation across all major sports, upon which innovative sports technology and media products can be built. This foundation will combine and connect sports data from all sources, which will create infinite possibilities. More information at https://infiniteathlete.ai/ ABOUT UNDER ARMOUR:
Under Armour, Inc., headquartered in Baltimore, Maryland, is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Designed to empower human performance, Under Armour's innovative products and experiences are engineered to make athletes better. For further information, please visit: http://about.underarmour.comMEDIA CONTACTS:Traci Otey Blunt, for Vincent Country - 202.368.6624; traci@blunt-groupstrategies.com
Amy Edwards, for Cigna Healthcare - amy.edwards@cignahealthcare.com
Erica Rumpke, for Playing for Keeps Association - 513.484.6795; e.rumpke@tencategrass.com
Therese Van Ryne, for Zebra Technologies – 847.370.2317; therese.vanryne@zebra.com
Ashleigh Wayland, for Stand Together - 703.328.7891; awayland@standtogether.org
Kali Caldwell, for Chick-fil-A Corporate, 404.668.5855; kali.caldwell@cfacorp.com
Megan Hanson, for Infinite Athlete, 701.640.1173; megan@infiniteathlete.ai
Yolanda Washington, for Google, ybwsahington@google.com
Morgan Evans, for Under Armour, 562.522.6485; morgan.evans@underarmour.com
Angela Reighard-Rand, for Chase, angela.reighard-rand@jpmchase.comSelect images from today's Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare can be found here.https://www.dropbox.com/scl/fo/9kywwk4wlu7s8dylt9t85/AHsm7SzSmWZWGKKcx8WpWNg?rlkey=nok8z0ih86bepl3aoxo1rdeo7&st=gjxjuexo&dl=0
View original content to download multimedia:https://www.prnewswire.com/news-releases/vincent-country-safe-zone-activity-day-presented-by-cigna-healthcare-delivers-super-bowl-week-fun-nfl-flag-football-and-wellness-to-oakland-students-302678336.htmlSOURCE Love Thy Neighbor CDC
Original: VINCENT COUNTRY SAFE ZONE ACTIVITY DAY PRESENTED BY CIGNA HEALTHCARE DELIVERS SUPER BOWL WEEK FUN, NFL FLAG FOOTBALL, AND WELLNESS TO OAKLAND STUDENTS
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
iHub News
5 months ago
BottomBounce
1 year ago
PonkenPlonken
2 years ago
Monksdream
2 years ago
QaB2i
6 years ago
whytestocks
6 years ago
tw0122
7 years ago
TFMG
7 years ago
Ichauway
7 years ago
EL CHAPO
7 years ago
tdeck
8 years ago
T695
9 years ago
ValueInvestor15
9 years ago
Register with Email
Hot Features
Premium
